Pricing Log in Create free account
Saturday 17 October 2026 Export PNTG’s income statement to Excel — free account

The Pennant Group, Inc.

PNTG Healthcare Medical Care Facilities

The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.8%, EPS grew 23.8%, free cash flow fell 50.9% and total debt rose 433.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

41.80 0.47 −1.11%
Market cap
$1.5B
P/E
44.5×
Fwd P/E
26.9×
Dividend yield
—
F-score
5/9
Altman Z
2.29
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.69
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — 1 — 2 3 — —
Insider Ownership 4.75%

Capital & Financial Ratios $m

Market Cap 1,480.00
Revenue 1,101.71
Net Income 38.45
Free Cash Flow 34.68
Net Debt 182.23
Current Ratio 1.20
Debt/Equity 0.49 (at or below 0.5: strong)
P/E ratio 44.47 (above 35: high)
Fwd P/E 26.90
P/S ratio 1.32
P/B ratio 3.60
Past 5Y EPS Growth 10.07%
This Y EPS Growth 18.28% (at or above 15%: strong)
Next Y EPS Growth 13.51%
Next Y revenue growth 24.93% (at or above 10%: strong)
Next 5Y EPS Growth 16.07% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.5×, against a ten-year median of 1.4×; over the ten years it ranged from 0.7× in 2023 to 4.2× in 2020.
P/E against its own 10 years 43.70%
10-year low 10-year high
P/S against its own 10 years 61.94%
10-year low 10-year high
P/B against its own 10 years 47.88%
10-year low 10-year high
EV/Sales against its own 10 years 58.61%
10-year low 10-year high
EV/FCF against its own 10 years 64.81%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 6 24 17 15
Receivables 61 81 123 133
Inventory — — — —
Other — — — —
80 123 167 184
2023 2024 2025 Q'26
Payables 11 19 25 26
ST’ Debt — — 5 5
Other — — — —
72 102 147 152

Compound Annual Growth %

10y 5y 3y
Sales — 19.37% 26.05%
Cash Flow — (0.77%) 74.79%
Earnings — 13.44% 64.51%
Book Value — 29.90% 43.88%

Revenue $m

Mar Jun Sep Dec Year
’26 285 298 — — —
’25 210 220 229 289 948
’24 157 169 181 189 695
’23 126 132 140 146 545
’22 114 116 118 125 473
’21 106 110 112 112 440
’20 92 93 98 108 391
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (3) 22 — — —
’25 (21) 35 14 21 48
’24 1 10 8 21 39
’23 9 7 12 5 33
’22 (4) 9 8 (4) 9
’21 (7) (5) (1) (5) (18)
’20 2 41 10 (3) 50
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (9) 15 — — —
’25 (23) 32 10 17 36
’24 (3) 9 7 17 30
’23 7 5 11 3 25
’22 (6) 3 6 (8) (5)
’21 (8) (6) (3) (7) (25)
’20 (1) 38 8 (2) 43
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.24 0.25 — — —
’25 0.22 0.20 0.17 0.24 0.84
’24 0.16 0.18 0.20 0.16 0.70
’23 0.06 0.09 0.15 0.14 0.44
’22 0.03 (0.09) 0.16 0.12 0.22
’21 0.03 0.09 0.04 (0.08) 0.09
’20 0.10 0.15 0.15 0.13 0.52
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — 6.15 9.40 17.52 8.68 10.00 13.77 21.18

Analyst estimates 2026–2028

Powerpack
High — — — 35.99 66.62 69.56 24.23 16.39 37.13 30.46
People
People Employees — — — — 5,223 6,441 5,335 5,791 7,000 9,700
Revenue/emp, $m 0.00 0.00 0.00 0.00 0.07 0.07 0.09 0.09 0.10 0.10
Income, $m
Income, $m Revenue 217 251 286 339 391 440 473 545 695 948
Gross margin, % 11.71 12.91 14.84 13.18 14.04 11.05 12.38 12.30 13.49 13.77
EBT 13 15 21 5 18 3 9 20 31 46
EBT margin, % 5.98 6.14 7.21 1.55 4.58 0.62 1.88 3.59 4.51 4.81
Net income 8 10 16 3 16 2 7 14 24 34
Depreciation 3 3 3 4 5 5 5 6 7 9
Per share, $
Per share, $ Revenue 7.76 9.02 10.28 12.16 13.95 15.48 16.28 18.25 22.29 27.42
Earnings 0.28 0.36 0.58 0.11 0.56 0.09 0.23 0.45 0.72 0.86
Cash flow 0.59 0.62 0.84 0.34 1.79 (0.64) 0.31 1.11 1.26 1.40
Capex 0.00 (0.09) (0.13) (0.24) (0.26) (0.22) (0.49) (0.27) (0.29) (0.35)
Free cash flow 0.59 0.53 0.71 0.10 1.53 (0.86) (0.18) 0.84 0.97 1.05
Book value 0.00 0.00 2.35 2.55 3.61 4.02 4.32 4.87 10.00 10.83
Shares, m 28 28 28 28 28 28 29 30 31 35
Valuation, ×
Valuation, × P/E 37.31 37.31 37.31 312.57 101.86 288.50 46.87 31.56 36.83 32.36
P/S 1.30 1.30 1.30 2.72 4.16 1.49 0.66 0.78 1.19 1.03
P/B 4.98 4.98 4.98 12.95 16.09 5.74 2.49 2.91 2.65 2.60
EV/Sales 2.05 2.05 2.05 2.81 4.22 1.63 0.83 0.91 1.54 1.19
EV/FCF 47.09 47.09 47.09 334.86 38.41 (29.27) (76.23) 19.94 35.40 31.16
Cash, $m
Cash, $m Operating cash flow 16 17 23 10 50 (18) 9 33 39 48
Capex (3) (3) (4) (7) (7) (6) (14) (8) (9) (12)
Free cash flow 16 15 20 3 43 (25) (5) 25 30 36
Balance, $m
Balance, $m Working capital — 0 0 (13) (29) 4 4 9 21 20
Total debt — — — 31 22 67 80 64 — 174
Net debt — 0 0 30 22 62 77 58 (24) 157
Shareholders’ equity — — 65 71 101 114 126 146 312 374
Returns, %
Returns, % ROA 0.00 10.58 31.96 0.93 3.30 0.52 1.27 2.54 3.70 3.59
ROIC — 0.00 19.76 3.49 9.57 1.66 3.92 7.73 8.28 6.11
ROE 0.00 17.80 26.08 3.73 18.28 2.50 5.54 9.87 9.86 8.62
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

The Pennant Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ARDT Ardent Health, Inc. $1.7B 21.7× 7.7× −1.40% (below 0%: shrinking) −76.92% (below 0%: shrinking) +121.70% (above 0%: growing) 100.00% 3.44% Compare
SNDA Sonida Senior Living, Inc. $1.7B — (loss-making) — (loss-making) +122.02% (above 0%: growing) n/m −291.70% (below 0%: shrinking) 34.97% (2.63%) Compare
CMPS COMPASS Pathways PLC Sponsored ADR $1.6B — (loss-making) — — n/m −4.18% (below 0%: shrinking) — 0.00% Compare
AMN AMN Healthcare Services Inc $1.6B 15.0× 31.2× +2.29% (above 0%: growing) n/m −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
AGL Agilon Health, Inc. $1.5B — (loss-making) — (loss-making) +7.15% (above 0%: growing) n/m −50.19% (below 0%: shrinking) 7.17% 0.79% Compare
PNTG The Pennant Group, Inc. $1.5B 44.5× 26.9× +35.76% (above 0%: growing) +23.81% (above 0%: growing) −50.94% (below 0%: shrinking) 14.07% 5.77%
HCSG Healthcare Services Group, Inc. $1.5B 12.2× 19.2× +2.69% (above 0%: growing) n/m −26.02% (below 0%: shrinking) 15.89% 4.72% Compare
NUTX Nutex Health Inc. $1.4B 7.1× 6.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
USPH U.S. Physical Therapy, Inc. $1.3B 504× 27.7× +8.47% (above 0%: growing) −56.90% (below 0%: shrinking) −8.24% (below 0%: shrinking) 19.59% 10.25% Compare
Median of peers $1.5B 15.0× 19.2× +2.69% — −17.13% 30.58% 3.72%

All 55 Medical Care Facilities stocks →

The Pennant Group, Inc. (PNTG) key facts

  • Strength: The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
  • Strength: Net income was $33.8 million, or $0.86 per share (basic), a net margin of 3.12%.
  • The Pennant Group, Inc. (PNTG) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, PNTG traded at $41.80, a market capitalization of $1.5 billion.
  • At that price the stock trades at 44.5× trailing-twelve-month earnings and 1.3× sales; its P/E is higher than 44% of its own readings over the past ten years.
  • Return on equity was 8.62% and debt-to-equity 0.49.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.29 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

The Pennant Group, Inc. (PNTG) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/PNTG · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com